SGH
TECH icon

Sivik Global Healthcare’s Bio-Techne TECH Stock Holding History

Sivik Global Healthcare’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,000
Closed -$2.65M – 47
2025
Q4 		$2.65M Buy
+45,000
New +$2.73M 0.77% 46
2021
Q4 		– Sell
-30,000
Closed -$3.63M – 56
2021
Q3 		$3.63M Buy
+30,000
New +$3.65M 0.87% 39
2018
Q2 		– Sell
-80,000
Closed -$3.02M – 73
2018
Q1 		$3.02M Buy
+80,000
New +$2.83M 1.41% 31
2017
Q4 		– Sell
-85,356
Closed -$2.58M – 81
2017
Q3 		$2.58M Buy
+85,356
New +$2.53M 0.88% 40

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sivik Global Healthcare's TECH Position: Q1 2026 in Review

Sivik Global Healthcare sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 45,000 shares — an estimated $2.65M sold.

Sivik Global Healthcare first reported a position in TECH in Q3 2017 and held it in 4 quarters. The position peaked at $3.63M in Q3 2021. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Sivik Global Healthcare reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Sivik Global Healthcare sold 45,000 Bio-Techne shares in Q1 2026, an estimated $2.65M.
  • Sivik Global Healthcare first reported a position in Bio-Techne in Q3 2017 and held it in 4 quarters.
  • Sivik Global Healthcare's Bio-Techne position peaked at $3.63M in Q3 2021.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Sivik Global Healthcare's 13F filing for Q1 2026, filed 15 Apr 2026.